Cargando…

Effectiveness and Tolerability of Colesevelam HCl for Accelerated Elimination of Teriflunomide in Healthy Participants

Detalles Bibliográficos
Autores principales:	Lunven, Catherine, Guo, Zuyu, Turpault, Sandrine, Delfolie, Astrid, Fauchoux, Nicolas, Turner, Timothy, Baldinetti, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Brief Report: Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484310/ https://www.ncbi.nlm.nih.gov/pubmed/28120422 http://dx.doi.org/10.1002/jcph.854

Ejemplares similares

Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide
por: Filali-Ansary, Aziz, et al.
Publicado: (2016)

Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly Patients
por: Gavin, James R., et al.
Publicado: (2014)

Effect of Colesevelam HCl Monotherapy on Lipid Particles in Type 2 Diabetes Mellitus
por: Rosenson, Robert S., et al.
Publicado: (2014)

Real-world utilization patterns and outcomes of colesevelam hcl in the ge electronic medical record
por: Hansen, Richard A, et al.
Publicado: (2013)

Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients
por: Bays, Harold E
Publicado: (2012)

Glucose and Low-Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes: Focus on Combination Therapy with Colesevelam HCl
por: Marrs, Joel C.
Publicado: (2012)

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy
por: Fonseca, Vivian A., et al.
Publicado: (2008)

Role of Colesevelam in Combination Lipid-Lowering Therapy
por: Jones, Michael R., et al.
Publicado: (2013)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children
por: Sonnett, Travis, et al.
Publicado: (2010)

Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and β-Cell Function
por: Marina, Anna L., et al.
Publicado: (2012)

Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
por: Bays, Harold, et al.
Publicado: (2007)

Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
por: Sekhri, Kavita, et al.
Publicado: (2011)

Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes
por: Nwose, Oliseyenum M., et al.
Publicado: (2013)

Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
por: Pavlou, Panagiotis, et al.
Publicado: (2021)

Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice
por: Cabré, Noemí, et al.
Publicado: (2021)

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
por: Kumar, Aditi, et al.
Publicado: (2023)

Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells
por: Turcotte, M L, et al.
Publicado: (2002)

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
por: Fonseca, Vivian A, et al.
Publicado: (2010)

Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development
por: Zhou, Enchen, et al.
Publicado: (2020)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults
por: Chughlay, M. Farouk, et al.
Publicado: (2022)

Tolerability and discontinuation rates in teriflunomide-treated patients: A real-world clinical experience
por: Alnajashi, Hind A., et al.
Publicado: (2018)

Single Ascending-Dose Study To Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects
por: Bruinenberg, Paul, et al.
Publicado: (2022)

Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects
por: O’Donnell, John, et al.
Publicado: (2019)

An update of teriflunomide for treatment of multiple sclerosis
por: Oh, Jiwon, et al.
Publicado: (2013)

Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)

Teriflunomide: Lack of efficacy: case report
Publicado: (2022)

Lichenoid Drug Eruption Induced by Teriflunomide
por: Agharbi, Fatima-Zahra, et al.
Publicado: (2023)

Efficacy, Safety, and Tolerability of ONO‐4474, an Orally Available Pan‐Tropomyosin Receptor Kinase Inhibitor, in Japanese Patients With Moderate to Severe Osteoarthritis of the Knee: A Randomized, Placebo‐Controlled, Double‐Blind, Parallel‐Group Comparative Study
por: Ishiguro, Naoki, et al.
Publicado: (2019)

Painful Small Fiber Neuropathy Associated With Teriflunomide: A Case Series and Literature Review Related to Teriflunomide and Leflunomide
por: Elrefaey, Ahmed, et al.
Publicado: (2023)

Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam – a clinical perspective
por: Goldberg, Ronald B
Publicado: (2009)

Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers
por: Sinxadi, Phumla, et al.
Publicado: (2020)

Leveraging the lymphohematopoietic graft-versus-host reaction (LGVHR) to achieve allograft tolerance and restore self tolerance with minimal toxicity
por: Sykes, Megan
Publicado: (2023)

Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
por: Jun, Soo Youn, et al.
Publicado: (2017)

Monocyte interaction accelerates HCl-induced lung epithelial remodeling
por: Chen, Qiuhua, et al.
Publicado: (2014)

Effect of Colesevelam on Liver Fat Quantified by Magnetic Resonance in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial
por: Le, Thuy-Anh, et al.
Publicado: (2012)

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2014)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu, Radu, et al.
Publicado: (2013)

Teriflunomide as a therapeutic means for myelin repair
por: Göttle, Peter, et al.
Publicado: (2023)

Neuropathy in multiple sclerosis patients treated with teriflunomide
por: Kilic, Ahmet Kasim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v6r9mpprd26gv7ksh4qmtulcbs